Refine
Year of publication
Document Type
- Article (87)
- Contribution to a Periodical (4)
- Preprint (2)
- Part of a Book (1)
Has Fulltext
- yes (94)
Is part of the Bibliography
- no (94)
Keywords
- NMR spectroscopy (14)
- SARS-CoV-2 (11)
- RNA (10)
- COVID19-NMR (5)
- G-quadruplexes (4)
- NMR (4)
- Solution NMR spectroscopy (4)
- Solution NMR-spectroscopy (4)
- rna (4)
- structural biology (4)
- 5′-UTR (3)
- Covid19-NMR (3)
- Mycobacterium tuberculosis (3)
- Non-structural protein (3)
- Protein drugability (2)
- RNA structures (2)
- aptamers (2)
- base pairing (2)
- biophysics (2)
- heteronuclear detection (2)
- kinetics (2)
- nuclear magnetic resonance spectroscopy (2)
- proteins (2)
- proteomics (2)
- reactive oxygen species (2)
- real-time NMR spectroscopy (2)
- small protein (2)
- small proteins (2)
- structure elucidation (2)
- 19F (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2'-deoxyguanosine riboswitch (1)
- 2-hydroxyglutarate (1)
- 2D NMR spectroscopy (1)
- 5'-UTR (1)
- 5_SL4 (1)
- ATG3 (1)
- B. subtilis (1)
- Bacterial Protein Kinases (1)
- Bacterial Protein Phosphatases (1)
- Biochemie (1)
- Biotin (1)
- Bradyrhizobium (1)
- C-mannosylation (1)
- CEST (1)
- COVID-19 (1)
- Covid19-nmr (1)
- DNA (1)
- DNA-PAINT (1)
- DNA-ligand complexes (1)
- Dimerization domain (1)
- Direct carbon (1)
- Drug Resistance (1)
- Drug discovery (1)
- Dynamische Kernpolarisation (1)
- E. coli (1)
- Echtzeit-NMR-Spektroskopie (1)
- Empfindlichkeitsverstärkung (1)
- Eph receptors (1)
- Ephrin ligand (1)
- Esters (1)
- Eukaryota (1)
- FBDD (1)
- FBS (1)
- FGFR (1)
- Fragment (1)
- G-protein-coupled receptors (1)
- G-quadruplex binders (1)
- Haloferax volcanii (1)
- HeLa cells (1)
- High-throughput screening (1)
- Hohes Magnetfeld (1)
- IDH mutation (1)
- IDH1 inhibitor (1)
- Internal ribosome entry site (1)
- Ligands (1)
- Low Molecular Weight PTP (1)
- Luciferase (1)
- Macrodomain (1)
- Methanosarcina mazei (1)
- Molecular modelling (1)
- MptpA (1)
- NMR Spectroscopy (1)
- NMR solution structure (1)
- NMR-Spektroskopie (1)
- NOESY (1)
- Nuclear magnetic resonance (1)
- Nucleic acid-binding domain (1)
- Nucleocapsid (1)
- Personalisierte Medizin (1)
- Phosphorylation (1)
- Primary metabolites (1)
- Protein druggability (1)
- Protein translation (1)
- PtkA (1)
- Quality control (1)
- RNA genome (1)
- RNA sequencing (RNA-Seq) (1)
- RNA stability (1)
- RNA synthesis (1)
- RNA therapy (1)
- RNASolution-state NMR (1)
- SHAPE analysis (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SSR128129E (1)
- Secondary metabolites (1)
- Shine-Dalgarno (1)
- Sinorhizobium fredii (1)
- Solubility (1)
- Solution-state NMR (1)
- Soybean (1)
- Stoffwechsel (1)
- Structural protein (1)
- TERRA RNA (1)
- Target validation (1)
- Translation initiation (1)
- UV/Vis spectroscopy (1)
- X-ray diffraction (1)
- Zellstudien (1)
- a-proteobacteria (1)
- accessory proteins (1)
- acute myeloid leukemia (1)
- adenine (1)
- alkylation (1)
- allostery (1)
- amino acids (1)
- analysis (1)
- analytical chemistry (1)
- antibiotics (1)
- autophagy (1)
- autophagy inhibition (1)
- barstar (1)
- biochemistry (1)
- biological chemistry (1)
- biological models (1)
- biophysical investigation (1)
- c-Myc (1)
- carbazole ligands (1)
- carbon direct detection (1)
- cell death (1)
- cell studies (1)
- cell-free protein synthesis (1)
- chemoenzymatic synthesis (1)
- chronic myeloid leukemia (1)
- circular dichroism (1)
- click chemistry (1)
- colorectal cancer (1)
- computational chemistry (1)
- conformation analysis (1)
- cysteine reactivity (1)
- cysteine-redox regulation (1)
- cytochromes (1)
- detection (1)
- diagnostic radiologic examination (1)
- drug design (1)
- entropy (1)
- eph receptor tyrosin kinase family (1)
- ephrins (1)
- fluorescence (1)
- fluorine (1)
- folding (1)
- folding landscapes (1)
- fragment screening (1)
- fragment-based screening (1)
- genetic code expansion (1)
- glioma (1)
- glutamine synthetase regulation (1)
- glutathione (1)
- glutathionylation (1)
- glycoproteins (1)
- guanidine riboswitch (1)
- hydroxynaphthoquinone (1)
- inhibitor (1)
- inhibitor design (1)
- intrinsically disordered protein (1)
- intrinsically disordered region (1)
- ions (1)
- isotope labeling (1)
- large functional RNAs (1)
- ligand design (1)
- ligands (1)
- ligases (1)
- light control (1)
- meta-stable structures (1)
- metabolic reprogramming (1)
- metabolic rewiring (1)
- metabolism (1)
- metals (1)
- molecular conformation (1)
- murine model (1)
- nitrogen direct detection (1)
- nitrogen regulation (1)
- nitroindoles (1)
- nitrosylation (1)
- non-canonical amino acid (1)
- non-natural nucleotide (1)
- nonstructural proteins (1)
- nucleobases (1)
- oligonucleotides (1)
- oncogene promoters (1)
- oxidases (1)
- oxidative folding (1)
- personalized medicine (1)
- photochemistry (1)
- plant symbioses (1)
- plasmid copy number (1)
- precision (1)
- proline isomerization (1)
- protein denaturation (1)
- protein folding (1)
- protein oxidation (1)
- protein phosphorylation (1)
- protein tyrosine kinase (1)
- protein tyrosine phosphatase (1)
- protons (1)
- quorum sensing (QS) (1)
- reductases (1)
- regioisomers (1)
- retinal (1)
- rhodopsin (1)
- ribosomal binding site (1)
- ribosomal exit tunnel (1)
- ribosome (1)
- riboswitches (1)
- ribozymes (1)
- roentgen rays (1)
- sORF (1)
- salmonella (1)
- selective isotopic labeling (1)
- site-specific labeling (1)
- small ORFs (1)
- small gene (1)
- small molecule inhibitor (1)
- solid-phase synthesis (1)
- spectrum (1)
- spectrum analysis (1)
- structural proteins (1)
- structure-activity relationships (1)
- structure–activity relationships (1)
- targeted therapy (1)
- temperature (1)
- temperature jump (1)
- thermometers (1)
- thiostrepton (1)
- transcription (1)
- transient complex (1)
- translation initiation region (1)
- tumor angiogenesis (1)
- tumor hypoxia (1)
- tumor perfusion (1)
- tyrosine kinase inhibitors (1)
- tyrosine kinase inhibitors. (1)
- tyrosine kinase signaling (1)
- zinc finger (1)
- µ-protein (1)
Institute
- Biochemie und Chemie (47)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (44)
- Biochemie, Chemie und Pharmazie (35)
- Exzellenzcluster Makromolekulare Komplexe (23)
- Sonderforschungsbereiche / Forschungskollegs (23)
- Biowissenschaften (19)
- Medizin (7)
- Präsidium (4)
- Georg-Speyer-Haus (3)
- Frankfurt Institute for Advanced Studies (FIAS) (1)
The SARS-CoV-2 virus is the cause of the respiratory disease COVID-19. As of today, therapeutic interventions in severe COVID-19 cases are still not available as no effective therapeutics have been developed so far. Despite the ongoing development of a number of effective vaccines, therapeutics to fight the disease once it has been contracted will still be required. Promising targets for the development of antiviral agents against SARS-CoV-2 can be found in the viral RNA genome. The 5′- and 3′-genomic ends of the 30 kb SCoV-2 genome are highly conserved among Betacoronaviruses and contain structured RNA elements involved in the translation and replication of the viral genome. The 40 nucleotides (nt) long highly conserved stem-loop 4 (5_SL4) is located within the 5′-untranslated region (5′-UTR) important for viral replication. 5_SL4 features an extended stem structure disrupted by several pyrimidine mismatches and is capped by a pentaloop. Here, we report extensive 1H, 13C, 15N and 31P resonance assignments of 5_SL4 as the basis for in-depth structural and ligand screening studies by solution NMR spectroscopy.
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
The SARS-CoV-2 (SCoV-2) virus is the causative agent of the ongoing COVID-19 pandemic. It contains a positive sense single-stranded RNA genome and belongs to the genus of Betacoronaviruses. The 5′- and 3′-genomic ends of the 30 kb SCoV-2 genome are potential antiviral drug targets. Major parts of these sequences are highly conserved among Betacoronaviruses and contain cis-acting RNA elements that affect RNA translation and replication. The 31 nucleotide (nt) long highly conserved stem-loop 5a (SL5a) is located within the 5′-untranslated region (5′-UTR) important for viral replication. SL5a features a U-rich asymmetric bulge and is capped with a 5′-UUUCGU-3′ hexaloop, which is also found in stem-loop 5b (SL5b). We herein report the extensive 1H, 13C and 15N resonance assignment of SL5a as basis for in-depth structural studies by solution NMR spectroscopy.
The stem-loop (SL1) is the 5'-terminal structural element within the single-stranded SARS-CoV-2 RNA genome. It is formed by nucleotides 7–33 and consists of two short helical segments interrupted by an asymmetric internal loop. This architecture is conserved among Betacoronaviruses. SL1 is present in genomic SARS-CoV-2 RNA as well as in all subgenomic mRNA species produced by the virus during replication, thus representing a ubiquitous cis-regulatory RNA with potential functions at all stages of the viral life cycle. We present here the 1H, 13C and 15N chemical shift assignment of the 29 nucleotides-RNA construct 5_SL1, which denotes the native 27mer SL1 stabilized by an additional terminal G-C base-pair.
In a previous study, EphB4 was demonstrated to be a positive regulator of A375-melanoma growth but a negative regulator of tumor vascularization and perfusion. To distinguish between EphB4 forward and ephrinB2 reverse signaling, we used the commercially available EphB4 kinase inhibitor NVP-BHG712 (NVP), which was later identified as its regioisomer NVPiso. Since there have been reported significant differences between the inhibition profiles of NVP and NVPiso, we compared the influence of NVP and NVPiso on tumor characteristics under the same experimental conditions. Despite the different inhibitory profiles of NVP and NVPiso, the comparative study conducted here showed the same EphB4-induced effects in vivo as in the previous investigation. This confirmed the conclusion that EphB4-ephrinB2 reverse signaling is responsible for increased tumor growth as well as decreased tumor vascularization and perfusion. These results are further substantiated by microarrays showing differences between mock-transfected and EphB4-transfected (A375-EphB4) cells with respect to at least 9 angiogenesis-related proteins. Decreased expression of vascular endothelial growth factor (VEGF), angiotensin 1 (Ang-1), and protein kinase B (Akt/PKB), together with the increased expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) and transforming growth factor beta-2 (TGF-β2), is consistent with the impaired vascularization of A375-EphB4 xenografts. Functional overexpression of EphB4 in A375-EphB4 cells was confirmed by activation of a variety of signaling pathways, including the Janus kinase/signal transducers and activators of transcription (JAK/STAT), rat sarcoma virus/rapidly accelerated fibrosarcoma/mitogen activated protein kinase kinase (Ras/Raf/MEK), and nuclear factor kappa-B (NFkB) pathways.
Despite the great interest in glycoproteins, structural information reporting on conformation and dynamics of the sugar moieties are limited. We present a new biochemical method to express proteins with glycans that are selectively labeled with NMR‐active nuclei. We report on the incorporation of 13C‐labeled mannose in the C‐mannosylated UNC‐5 thrombospondin repeat. The conformational landscape of the C‐mannose sugar puckers attached to tryptophan residues of UNC‐5 is characterized by interconversion between the canonical 1C4 state and the B03 / 1S3 state. This flexibility may be essential for protein folding and stabilization. We foresee that this versatile tool to produce proteins with selectively labeled C‐mannose can be applied and adjusted to other systems and modifications and potentially paves a way to advance glycoprotein research by unravelling the dynamical and conformational properties of glycan structures and their interactions.
Genetic code expansion facilitates position-selective modification of nucleic acids and proteins
(2020)
Transcription and translation obey to the genetic code of four nucleobases and 21 amino acids evolved over billions of years. Both these processes have been engineered to facilitate the use of non-natural building blocks in both nucleic acids and proteins, enabling researchers with a decent toolbox for structural and functional analyses. Here, we review the most common approaches for how labeling of both nucleic acids as well as proteins in a site-selective fashion with either modifiable building blocks or spectroscopic probes can be facilitated by genetic code expansion. We emphasize methodological approaches and how these can be adapted for specific modifications, both during as well as after biomolecule synthesis. These modifications can facilitate, for example, a number of different spectroscopic analysis techniques and can under specific circumstances even be used in combination.
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's disease. We describe herein the investigation of disease-relevant small amyloid-β oligomers by mass spectrometry and ion mobility spectrometry, revealing functionally relevant structural attributes. In particular, we can show that amyloid-β oligomers develop in two distinct arrangements leading to either neurotoxic oligomers and fibrils or non-toxic amorphous aggregates. Comprehending the key-attributes responsible for those pathways on a molecular level is a pre-requisite to specifically target the peptide's tertiary structure with the aim to promote the emergence of non-toxic aggregates. Here, we show for two fibril inhibiting ligands, an ionic molecular tweezer and a hydrophobic peptide that despite their different interaction mechanisms, the suppression of the fibril pathway can be deduced from the disappearance of the corresponding structure of the first amyloid-β oligomers.